Joon Ho Moon

Cyclin D1 Overexpression, p16 Loss, and pRb Inactivation Play a Key Role in Pulmonary Carcinogenesis and have a Prognostic Implication for the long-term Survival in Non-small Cell Lung Carcinoma Patients

Y. Chae, Shi-Nae Kim, Soo Jung Lee, 2009 .

Immunoglobulin D multiple myeloma: response to therapy, survival, and prognostic factors in 75 patients.

H. Eom, C. Suh, S. S. Yoon, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

A multi-center and non-interventional registry of brentuximab vedotin in patients with relapsed or refractory CD30-positive lymphoma: the CISL1803/BRAVO study

H. Eom, J. Jo, Deok-Hwan Yang, 2023, Blood research.

Outcome of Multiple Myeloma Patients With Hepatitis Surface Antigen: Korean Multiple Myeloma Working Party 2103 Study.

H. Yhim, Y. Yuh, S. Jung, 2023, Clinical lymphoma, myeloma & leukemia.

Development of a new risk stratification system for patients with newly diagnosed multiple myeloma using R-ISS and 18F-FDG PET/CT

C. Hong, S. Jeong, Kihyun Kim, 2021, Blood Cancer Journal.

Synergistic Effect of Venetoclax and Bendamustine in Early T-cell Precursor Acute Lymphoblastic Leukemia

D. Baek, H. Cho, Juhyung Kim, 2024, In Vivo.